SCHEMBL29800050

SCHEMBL29800050

COC(=O)c1c(N(CCc2ccccc2)C(C)=O)sc2cc(O)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.42
▸ PKM P14618 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ GAA P10253 2/20 0.42
▸ HSP90AA1 P07900 3/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ LMNA P02545 4/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ TSHR P16473 1/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ SNCA P37840 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24683885 1.00 MAPT (0.42) MAPTPKMALDH1A1GAAHSP90AA1
SCHEMBL24682178 0.89 MAPT (0.43) MAPTPKMALDH1A1GAAHSP90AA1
SCHEMBL29800041 0.89 MAPT (0.43) MAPTPKMALDH1A1GAAHSP90AA1
SCHEMBL30701682 0.86 MAOB (0.38) MAPTPKMALDH1A1GAAHSP90AA1
SCHEMBL24683195 0.86 MAOB (0.38) MAPTPKMALDH1A1GAAHSP90AA1
SCHEMBL24683177 0.81 MAPK8 (0.41) MAPTPKMALDH1A1GAAALOX5
SCHEMBL29799932 0.81 MAOB (0.40) MAPTPKMALDH1A1GAAHSP90AA1
SCHEMBL24682825 0.81 MAOB (0.40) MAPTPKMALDH1A1GAAHSP90AA1
SCHEMBL30664687 0.81 MAPK8 (0.41) MAPTPKMALDH1A1GAAALOX5
SCHEMBL24682179 0.81 MAPT (0.45) MAPTPKMALDH1A1GAAHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed
WO-2022173329-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Акционерное общество "Отисифарм" 2022-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 MAPT 1064/4885PKM 2167/4885ALDH1A1 259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback